Kromek Group PLC

Receive alerts
Market Cap:
£60.22 m
17.48 GBX
52 weeks high
52 weeks low

Vision and Strategy

The Board's current business strategy comprises the following aspects:

Our Vision
To be the world-leading provider of multispectral radiation detection products and technologies to enable customers and users to take better decisions based on better information.

Increased product integration
Kromek aims to satisfy increasing customer demand for more integrated and complete solutions. Following the acquisition of eV Products, the Board plans to fully integrate its products into the Group's existing offering and develop enhanced solutions.

Further commercialisation of the core technology
The Group plans to further commercialise its core technology through new product development for existing core markets, expansion into new geographical markets with existing products, including the opening of a sales office in Germany, and through licensing its technology in new market sectors.

In particular, the Directors believe that new modalities of nuclear detection, including further forms of cancer screening, as well as a continuing trend for networked sensors will create significant additional opportunities.

Enhanced OEM relationships
The Group will continue to supply its products and subcomponents to OEMs, and will aim to convert its current development contracts into long-term supply agreements. Additionally, the Group will target the development of new key relationships with further OEM partners in its target markets.


Kromek has a portfolio of products for specific detection, identification and quantification of radioactive materials, which are differentiated by their sensitivity, high resolution and small form factor allowing unprecedented flexibility in deployment. Applications include civil radiation detection, industrial process control, environmental monitoring and personal detection use for the public.

For more information, please click here


Kromek offers detectors and subcomponents for OEM customers in the medical imaging market including CT, SPECT, PET and Bone Mineral Densitometry. Colour imaging enables earlier, more reliable detection of cancer, cardiac conditions and osteoporosis with lower doses of radiation - resulting in better patient outcomes.

For more information, please click here


OEM Solutions



Standard ASICs for x-ray and gamma ray applications

Modern high performance detection systems depend on state-of-the-art ASIC based readout electronics. Whether it is high-energy resolution, high-spatial resolution or high count rate, NOVA ASICs offer a combination of unsurpassed speed and functionality.

For more information, please click here


Kromek has a diverse technology base and is building expertise based on its core competence of materials technology and advanced x-ray imaging architecture. The company's ability to produce single crystals in the Cadmium Telluride (CdTe) family of materials, on a commercial basis, has enabled it to exploit their energy selectivity in a range of innovative products having both imaging and non imaging applications.

For more information, please click here

Dr Arnab Basu MBE
Dr Arnab has a PhD in physics from Durham University, specialising in semiconducting sensor materials. Arnab held senior management positions in his family business, which manufactured materials for the electronics industry serving over 250 major telecommunications and consumer electronics manufacturers, including Siemens, GEC. He worked in commercial product development for Elmwood Sensors Ltd, (Honeywell Group, UK). A prominent figure within the business community, he was awarded Ernst and Young ‘Entrepreneur of the Year’ (2009) and received an MBE for services to regional development and international trade (2014).

Mr Derek Bulmer
A qualified Chartered Accountant and Barrister, Derek has worked with KPMG and undertaken a number of senior management roles with blue chip plc’s including Bass plc, AWG plc and Ibstock plc. Additionally, and more recently, a number of roles as Finance Director of privately owned groups in both the IT and oil and gas industries have provided a wealth of experience in executing and managing business acquisitions plus significant aspects of the commercial and legal disciplines of corporate management.

Mr Berry Beumer
A technology business executive with extensive experience of delivering revenue growth in analytical instrument, high-frequency communications equipment and optoelectronic and semiconductor materials industries. He has held a number of senior roles while working both in Europe and the US with AkzoNobel and Allied Signal and was Division President and General Manager of Taconic’s US, Europe and Asia operations. Recently he has held the position of Vice President in the areas of Sales and Marketing at XOS, Inc. During his tenure he was responsible for driving the strategic direction of their x-ray elemental technology business, positioning the company as a global leader in the area of application specific elemental analysis solutions for the petroleum and consumer products industries.

Mr Ian Radley
Ian has a BSc in Applied Physics and Chemistry from Durham University. He has nearly 35 years experience in scientific instrumentation and has spent the last twenty years in technology and operations management. His background includes thermal imaging sensors, superconducting magnet systems, x-ray tubes, x-ray detectors and x-ray optics. He spent 11 years in the US as operations director for Oxford Instruments X-ray Technology Group and as director of advanced product development for X-ray Optical Systems (XOS Inc.).


General Enquiries
+44 (0) 1740 626060
[email protected]

Public Relations and Media
+44 (0) 1740 626064

Sales Enquiries
+44 (0) 1740 626060
[email protected]

Customer Support
+44 (0) 1740 626050
[email protected]

Financial Adviser, Nominated Adviser and Broker
Cenkos Securities plc
6.7.8 Token House Yard

Reporting Accountants and Auditors
Deloitte LLP
One Trinity Gardens
Broad Chare
Newcastle upon Tyne

Lawyers to the Company
Pinsent Masons LLP
1 Park Row

Capita Asset Services
The Registry
34 Beckenham Road

Financial PR Advisers
Luther Pendragon Ltd
3 Priory Court

Number of Securities in Issue
The total number of Ordinary Shares of 1p each in the capital of the Company in issue on 28 February 2019 was 344,559,089 shares, with each share carrying the right to one vote.

The percentage of shares not in public hands is 21.47%.

There are no restrictions on the transfer of securities.

UK City Code on Takeovers and Mergers

Kromek Group plc is subject to the UK City Code on Takeovers and Mergers.

This section was last updated on 19 March 2019.




Dr Arnab Basu
Chief Executive Officer
Reporting Accountants and Auditors
1 Sovereign Square
Sovereign Street

Company Secretary/ 
In-House Counsel
Derek Bulmer

Lawyers to the Company
Eversheds LLP
Bridgewater Place
Water Lane
LS11 5DR

Registered Office
Thomas Wright Way
TS21 3FD
Link Asset Services
The Registry
34 Beckenham Road

Financial Adviser, 
Nominated Adviser and Joint Broker
Cenkos Securities plc
6.7.8 Token House Yard

Joint Broker
Cantor Fitzgerald Europe
One Churchill Place
Canary Wharf
E14 5RB

Financial PR Advisers
Luther Pendragon Ltd
Second Floor 
48 Gracechurch Street